Stock Analysts’ price target changes for Tuesday, March 10th:
Accenture (NYSE:ACN) had its target price lowered by Truist Financial Corporation from $317.00 to $260.00. The firm currently has a buy rating on the stock.
ACT Energy Technologies (TSE:ACX) had its target price increased by ATB Cormark Capital Markets from C$7.25 to C$8.00. They currently have an outperform rating on the stock.
ACT Energy Technologies (TSE:ACX) had its price target boosted by Raymond James Financial, Inc. from C$9.50 to C$10.50. They currently have an outperform rating on the stock.
Adobe (NASDAQ:ADBE) had its target price reduced by TD Cowen from $400.00 to $325.00. TD Cowen currently has a hold rating on the stock.
Amazon.com (NASDAQ:AMZN) had its price target increased by Wolfe Research from $250.00 to $255.00. They currently have an outperform rating on the stock.
Aecon Group (TSE:ARE) had its price target boosted by Raymond James Financial, Inc. from C$33.00 to C$41.00. Raymond James Financial, Inc. currently has a market perform rating on the stock.
Aecon Group (TSE:ARE) had its target price raised by Royal Bank Of Canada from C$30.00 to C$41.00. Royal Bank Of Canada currently has a sector perform rating on the stock.
Portman Ridge Finance (NASDAQ:BCIC) had its price target lowered by Keefe, Bruyette & Woods from $14.00 to $9.00. They currently have a market perform rating on the stock.
BETA Technologies (NYSE:BETA) had its target price cut by Morgan Stanley from $34.00 to $33.00. Morgan Stanley currently has an overweight rating on the stock.
BETA Technologies (NYSE:BETA) had its target price cut by Jefferies Financial Group Inc. from $30.00 to $29.00. They currently have a buy rating on the stock.
BioAge Labs (NASDAQ:BIOA) had its target price increased by Citigroup Inc. from $15.00 to $52.00. Citigroup Inc. currently has a buy rating on the stock.
Beachbody (NASDAQ:BODI) had its price target increased by Canaccord Genuity Group Inc. from $9.00 to $12.00. Canaccord Genuity Group Inc. currently has a buy rating on the stock.
Byrna Technologies (NASDAQ:BYRN) had its price target lowered by B. Riley Financial, Inc. from $46.00 to $31.00. The firm currently has a buy rating on the stock.
Casey’s General Stores (NASDAQ:CASY) had its price target boosted by Royal Bank Of Canada from $662.00 to $713.00. They currently have a sector perform rating on the stock.
Celcuity (NASDAQ:CELC) had its target price raised by Needham & Company LLC from $95.00 to $122.00. The firm currently has a buy rating on the stock.
Calian Group (TSE:CGY) had its price target increased by Ventum Financial from C$84.00 to C$94.00. The firm currently has a buy rating on the stock.
Community Healthcare Trust (NYSE:CHCT) had its price target reduced by Truist Financial Corporation from $20.00 to $19.00. They currently have a buy rating on the stock.
Choice Hotels International (NYSE:CHH) had its price target reduced by Morgan Stanley from $91.00 to $83.00. Morgan Stanley currently has an underweight rating on the stock.
Chewy (NYSE:CHWY) had its target price trimmed by TD Cowen from $48.00 to $39.00. The firm currently has a buy rating on the stock.
Chewy (NYSE:CHWY) had its price target lowered by Morgan Stanley from $51.00 to $50.00. The firm currently has an overweight rating on the stock.
Climb Bio (NASDAQ:CLYM) had its target price raised by HC Wainwright from $11.00 to $15.00. HC Wainwright currently has a buy rating on the stock.
CNH Industrial (NYSE:CNH) had its price target trimmed by Citigroup Inc. from $15.00 to $13.00. They currently have a buy rating on the stock.
Costco Wholesale (NASDAQ:COST) had its target price increased by Daiwa Securities Group Inc. from $917.00 to $975.00. The firm currently has a neutral rating on the stock.
Corebridge Financial (NYSE:CRBG) had its target price trimmed by TD Cowen from $38.00 to $35.00. TD Cowen currently has a buy rating on the stock.
Corbus Pharmaceuticals (NASDAQ:CRBP) had its target price boosted by Oppenheimer Holdings, Inc. from $53.00 to $57.00. They currently have an outperform rating on the stock.
Salesforce (NYSE:CRM) had its target price cut by Northland Securities from $267.00 to $229.00. They currently have a market perform rating on the stock.
CrowdStrike (NASDAQ:CRWD) had its target price reduced by Daiwa Securities Group Inc. from $560.00 to $500.00. They currently have an outperform rating on the stock.
Constellation Software (TSE:CSU) had its target price cut by BMO Capital Markets from C$4,600.00 to C$4,200.00.
Constellation Software (TSE:CSU) had its target price lowered by Canadian Imperial Bank of Commerce from C$4,688.00 to C$4,610.00. They currently have an outperform rating on the stock.
Constellation Software (TSE:CSU) had its price target cut by Raymond James Financial, Inc. from C$4,300.00 to C$3,700.00. The firm currently has a market perform rating on the stock.
Constellation Software (TSE:CSU) had its target price boosted by National Bank Financial from C$3,200.00 to C$3,400.00. They currently have a sector perform rating on the stock.
Constellation Software (TSE:CSU) had its target price increased by TD Securities from C$4,000.00 to C$4,100.00. The firm currently has a buy rating on the stock.
CSX (NASDAQ:CSX) had its target price raised by Wolfe Research from $42.00 to $44.00. They currently have an outperform rating on the stock.
Dianthus Therapeutics (NASDAQ:DNTH) had its price target increased by Robert W. Baird from $67.00 to $132.00. The firm currently has an outperform rating on the stock.
Dianthus Therapeutics (NASDAQ:DNTH) had its target price boosted by Wedbush from $55.00 to $80.00. Wedbush currently has an outperform rating on the stock.
Design Therapeutics (NASDAQ:DSGN) had its target price increased by Royal Bank Of Canada from $13.00 to $14.00. They currently have an outperform rating on the stock.
Distribution Solutions Group (NASDAQ:DSGR) had its target price reduced by Barrington Research from $41.00 to $35.00. The firm currently has an outperform rating on the stock.
Entain (LON:ENT) had its price target cut by Citigroup Inc. from GBX 1,150 to GBX 1,100. The firm currently has a buy rating on the stock.
Energy Transfer (NYSE:ET) had its target price raised by Morgan Stanley from $19.00 to $21.00. The firm currently has an equal weight rating on the stock.
FuelCell Energy (NASDAQ:FCEL) had its price target reduced by Wells Fargo & Company from $7.00 to $6.00. The firm currently has an underweight rating on the stock.
Five Below (NASDAQ:FIVE) had its target price boosted by Barclays PLC from $193.00 to $211.00. Barclays PLC currently has an equal weight rating on the stock.
Fluent (NASDAQ:FLNT) had its target price boosted by Canaccord Genuity Group Inc. from $2.50 to $3.50. Canaccord Genuity Group Inc. currently has a hold rating on the stock.
Gaming and Leisure Properties (NASDAQ:GLPI) had its price target boosted by Scotiabank from $48.00 to $50.00. Scotiabank currently has a sector perform rating on the stock.
Greggs (LON:GRG) had its price target lowered by Royal Bank Of Canada from GBX 1,970 to GBX 1,830. They currently have an outperform rating on the stock.
Hyatt Hotels (NYSE:H) had its price target trimmed by Morgan Stanley from $194.00 to $185.00. They currently have an overweight rating on the stock.
HCA Healthcare (NYSE:HCA) had its target price boosted by TD Cowen from $529.00 to $561.00. TD Cowen currently has a buy rating on the stock.
Hims & Hers Health (NYSE:HIMS) had its target price boosted by Deutsche Bank Aktiengesellschaft from $25.00 to $28.00. They currently have a hold rating on the stock.
Hilton Worldwide (NYSE:HLT) had its target price lowered by Morgan Stanley from $306.00 to $303.00. They currently have an overweight rating on the stock.
Hewlett Packard Enterprise (NYSE:HPE) had its price target raised by Morgan Stanley from $23.00 to $25.00. The firm currently has an equal weight rating on the stock.
Hewlett Packard Enterprise (NYSE:HPE) had its target price raised by Bank of America Corporation from $29.00 to $32.00. They currently have a buy rating on the stock.
Intchains Group (NASDAQ:ICG) had its price target lowered by Benchmark Co. from $4.00 to $3.00. The firm currently has a buy rating on the stock.
Korn/Ferry International (NYSE:KFY) had its target price lowered by Truist Financial Corporation from $88.00 to $75.00. They currently have a buy rating on the stock.
Kinetik (NYSE:KNTK) had its target price boosted by Royal Bank Of Canada from $46.00 to $49.00. The firm currently has an outperform rating on the stock.
LiqTech International (NASDAQ:LIQT) had its target price boosted by Ascendiant Capital Markets from $4.20 to $4.30. Ascendiant Capital Markets currently has a buy rating on the stock.
Lam Research (NASDAQ:LRCX) had its target price increased by Barclays PLC from $250.00 to $255.00. The firm currently has an equal weight rating on the stock.
Lexicon Pharmaceuticals (NASDAQ:LXRX) had its target price raised by Citigroup Inc. from $2.10 to $2.30. Citigroup Inc. currently has a buy rating on the stock.
LyondellBasell Industries (NYSE:LYB) had its price target boosted by Jefferies Financial Group Inc. from $51.00 to $70.00. Jefferies Financial Group Inc. currently has a hold rating on the stock.
Mid-America Apartment Communities (NYSE:MAA) had its target price reduced by Truist Financial Corporation from $146.00 to $142.00. The firm currently has a buy rating on the stock.
Marriott International (NASDAQ:MAR) had its target price increased by Morgan Stanley from $328.00 to $331.00. Morgan Stanley currently has an overweight rating on the stock.
Methanex (NASDAQ:MEOH) (TSE:MX) had its price target increased by Raymond James Financial, Inc. from $45.00 to $50.00. The firm currently has a market perform rating on the stock.
MidCap Financial Investment (NASDAQ:MFIC) had its price target trimmed by Keefe, Bruyette & Woods from $13.00 to $11.50. Keefe, Bruyette & Woods currently has a market perform rating on the stock.
MacroGenics (NASDAQ:MGNX) had its price target boosted by Barclays PLC from $3.00 to $4.00. The firm currently has an overweight rating on the stock.
Vail Resorts (NYSE:MTN) had its price target lowered by Stifel Nicolaus from $175.00 to $172.00. They currently have a buy rating on the stock.
Vail Resorts (NYSE:MTN) had its price target reduced by Truist Financial Corporation from $234.00 to $217.00. The firm currently has a buy rating on the stock.
Vail Resorts (NYSE:MTN) had its target price reduced by Barclays PLC from $140.00 to $138.00. Barclays PLC currently has an underweight rating on the stock.
Nature’s Sunshine Products (NASDAQ:NATR) had its target price raised by Canaccord Genuity Group Inc. from $22.00 to $29.00. The firm currently has a buy rating on the stock.
Nexus Industrial REIT (TSE:NXR.UN) had its price target trimmed by Desjardins from C$9.00 to C$8.50. Desjardins currently has a buy rating on the stock.
Nayax (NASDAQ:NYAX) had its target price boosted by Keefe, Bruyette & Woods from $52.00 to $60.00. They currently have a market perform rating on the stock.
Oceaneering International (NYSE:OII) had its price target boosted by Citigroup Inc. from $25.00 to $35.00. The firm currently has a neutral rating on the stock.
Oracle (NYSE:ORCL) had its price target lowered by Robert W. Baird from $300.00 to $200.00. They currently have an outperform rating on the stock.
Palladyne AI (NASDAQ:PDYN) had its target price boosted by Jefferies Financial Group Inc. from $7.00 to $8.00. Jefferies Financial Group Inc. currently has a hold rating on the stock.
Progressive (NYSE:PGR) had its price target cut by Bank of America Corporation from $315.00 to $308.00. The firm currently has a buy rating on the stock.
Paramount Skydance (NASDAQ:PSKY) had its target price trimmed by Bank of America Corporation from $13.00 to $11.00. They currently have an underperform rating on the stock.
Reddit (NYSE:RDDT) had its price target cut by Jefferies Financial Group Inc. from $285.00 to $250.00. They currently have a buy rating on the stock.
RideNow Group (NASDAQ:RDNW) had its price target increased by Robert W. Baird from $5.00 to $7.00. They currently have a neutral rating on the stock.
Repay (NASDAQ:RPAY) had its target price trimmed by Benchmark Co. from $8.00 to $6.00. They currently have a buy rating on the stock.
Rentokil Initial (NYSE:RTO) had its target price raised by Oppenheimer Holdings, Inc. from $30.00 to $35.00. They currently have an outperform rating on the stock.
SAB Biotherapeutics (NASDAQ:SABS) had its target price reduced by HC Wainwright from $9.00 to $7.00. The firm currently has a buy rating on the stock.
Strathcona Resources (TSE:SCR) was given a C$40.00 target price by analysts at Roth Mkm. The firm currently has a buy rating on the stock.
Solaris Energy Infrastructure (NYSE:SEI) had its target price trimmed by Citigroup Inc. from $62.00 to $61.00. Citigroup Inc. currently has a buy rating on the stock.
The Sage Group (LON:SGE) had its price target lowered by Citigroup Inc. from GBX 1,400 to GBX 1,150. The firm currently has a buy rating on the stock.
Spruce Biosciences (NASDAQ:SPRB) had its target price reduced by Citizens Jmp from $180.00 to $170.00. They currently have a market outperform rating on the stock.
Sarepta Therapeutics (NASDAQ:SRPT) had its price target raised by Citigroup Inc. from $8.00 to $9.00. The firm currently has a sell rating on the stock.
Talos Energy (NYSE:TALO) had its target price boosted by Citigroup Inc. from $14.00 to $16.00. Citigroup Inc. currently has a buy rating on the stock.
Turtle Beach (NASDAQ:TBCH) had its price target lowered by B. Riley Financial, Inc. from $21.00 to $20.00. The firm currently has a buy rating on the stock.
UFP Industries (NASDAQ:UFPI) had its price target lowered by DA Davidson from $112.00 to $110.00. They currently have a buy rating on the stock.
Ulta Beauty (NASDAQ:ULTA) had its price target increased by Canaccord Genuity Group Inc. from $674.00 to $799.00. Canaccord Genuity Group Inc. currently has a buy rating on the stock.
Vitalhub (TSE:VHI) had its price target lowered by ATB Cormark Capital Markets from C$16.50 to C$15.00. They currently have an outperform rating on the stock.
Vertex Pharmaceuticals (NASDAQ:VRTX) had its price target increased by HC Wainwright from $591.00 to $641.00. They currently have a buy rating on the stock.
Vertex Pharmaceuticals (NASDAQ:VRTX) had its price target raised by Oppenheimer Holdings, Inc. from $540.00 to $600.00. They currently have an outperform rating on the stock.
Vertex Pharmaceuticals (NASDAQ:VRTX) had its target price boosted by Morgan Stanley from $570.00 to $596.00. Morgan Stanley currently has an overweight rating on the stock.
Vertex Pharmaceuticals (NASDAQ:VRTX) had its price target boosted by Citigroup Inc. from $575.00 to $585.00. They currently have a buy rating on the stock.
Vertex Pharmaceuticals (NASDAQ:VRTX) had its target price boosted by Bank of America Corporation from $571.00 to $598.00. Bank of America Corporation currently has a buy rating on the stock.
Vistry Group (LON:VTY) had its target price trimmed by JPMorgan Chase & Co. from GBX 640 to GBX 530. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Western Alliance Bancorporation (NYSE:WAL) had its target price trimmed by DA Davidson from $105.00 to $93.00. They currently have a buy rating on the stock.
Wyndham Hotels & Resorts (NYSE:WH) had its price target lowered by Morgan Stanley from $89.00 to $85.00. Morgan Stanley currently has an overweight rating on the stock.
WAVE Life Sciences (NASDAQ:WVE) had its target price raised by Canaccord Genuity Group Inc. from $43.00 to $52.00. Canaccord Genuity Group Inc. currently has a buy rating on the stock.
Xenon Pharmaceuticals (NASDAQ:XENE) had its target price raised by Deutsche Bank Aktiengesellschaft from $56.00 to $90.00. The firm currently has a buy rating on the stock.
Xenon Pharmaceuticals (NASDAQ:XENE) had its target price boosted by HC Wainwright from $53.00 to $74.00. They currently have a buy rating on the stock.
Xenon Pharmaceuticals (NASDAQ:XENE) had its target price raised by Wedbush from $47.00 to $64.00. They currently have an outperform rating on the stock.
Xenon Pharmaceuticals (NASDAQ:XENE) had its target price raised by Wells Fargo & Company from $49.00 to $68.00. The firm currently has an overweight rating on the stock.
Yext (NYSE:YEXT) had its price target trimmed by B. Riley Financial, Inc. from $10.00 to $8.00. The firm currently has a buy rating on the stock.
Zscaler (NASDAQ:ZS) had its target price lowered by Oppenheimer Holdings, Inc. from $280.00 to $250.00. The firm currently has an outperform rating on the stock.
Receive News & Ratings for Accenture PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accenture PLC and related companies with MarketBeat.com's FREE daily email newsletter.
